Biomanufacturing has produced important materials, ingredients, therapeutics, and more for decades, yet it is still far from a mature industry. Given life’s 3.5 billion years of experimentation on Earth, it takes a lot of effort and resources to fully unleash nature’s potential for societal gain.
That said, biomanufacturing is entering a new age, spurred by the growth of synthetic biology and renewed investment in bioprocess innovations and technologies. Many have referred to this biomanufacturing renaissance as the next industrial revolution — a biorevolution.
Here’s the catch. To really bring forth an industrial biorevolution, new biomanufacturing approaches must help solve biotechnology’s age-old commercial hurdle: how to scale up manufacturing.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect